Access all of the content
touchONCOLOGY joins Dr Deborah Doroshow to discuss the recent COVID-19 and Cancer Outcomes Study (CCOS), and how the COVID-19 pandemic has caused disparities in cancer care. Dr Doroshow presented her late-breaking abstract, ‘Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS)‘ (LBA74) at the Virtual 2020 ESMO Congress, 19–21 September 2020.
- What were the biggest challenges faced by cancer care providers during the COVID-19 pandemic? (0:14)
- What factors predispose cancer patients to increased risk for COVID-19-related morbidity and mortality? (1:12)
- Could you tell us about the aims and design of the CCOS study? (2:23)
- What were the major findings of the study? (5:01)
- What are the reasons for these disparities and what can be done to mitigate the effects of COVID-19? (6:02)
- Is there anything you would like to highlight in relation to the CCOS study? (7:22)
Speaker Disclosure: Deborah Doroshow has nothing to disclose in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the Virtual 2020 ESMO Congress.
Share this Video
Related Videos In COVID-19
Mark Lawler, European Cancer Summit 2021: Time To Act: COVID-19 & Cancer Campaign
We were delighted to catch up with Prof Mark Lawler to discuss the challenges that the COVID-19 pandemic has had on cancer care in Europe, and the key objectives and messages of the Time To Act: COVID-19 & Cancer campaign. Questions 1. What has been the impact of the COVID-19 pandemic on cancer screening and […]
Scott Shepherd, ESMO 2021: The CAPTURE Study: Adaptive Immunity to SARS-CoV-2 Infection and Vaccination in Cancer Patients (Part Two)
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part One click here. Questions 1. How did immune responses relate to cancer stage and disease status? (00:18-03:26) 2. What are the implications of […]
Scott Shepherd, ESMO 2021: The CAPTURE Study: Adaptive Immunity to SARS-CoV-2 Infection and Vaccination in Cancer Patients (Part One)
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part Two click here. Questions 1. What were the aims and design of the CAPTURE study? (00:18-02:25) 2. What were the study findings in […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!